Fecal Calprotectin Measurement is a Marker of Short-Term Clinical Outcome and Presence of Mucosal Healing in Patients with Inflammatory Bowel Disease


A.Kostas, S.I. Siakavellas, et al. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease. World Journal of GastroenterologyNovember 2017. PMID: 29151692 DOI: 10.3748/wjg.v23.i41.7387.

Highlights from this Publication

“In our patient cohort, we were able to define an optimal cut-off FC value of 261 µg/g, which had a strong predictive value for the discrimination of future relapses vs maintenance of remission.”

BÜHLMANN fCAL® ELISA is FDA 510(k) cleared. For in vitro Diagnostic Use.

Health Canada License: 80726